GlaxoSmithKline Looks to Unload Another Brand

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Private equity firms Blackstone (BX.N) and Lion Capital have teamed up to make a formal bid worth more than a billion pounds for Lucozade and Ribena, the two soft drink brands put up for sale by drugmaker GlaxoSmithKline (GSK.L), Sky News reported on Sunday.

Help employers find you! Check out all the jobs and post your resume.

Back to news